Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab

Published:2011-03-15 Issue:5 Volume:41 Page:593-599
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Chang H. J.,Han S.-W.,Oh D.-Y.,Im S.-A.,Jeon Y. K.,Park I. A.,Han W.,Noh D.-Y.,Bang Y.-J.,Kim T.-Y.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/41/5/593/5160942/hyr020.pdf

Reference33 articles.

1. Cancer Statistics, 2009

2. Nationwide Cancer Incidence in Korea, 2003-2005

3. Estrogen receptor and breast cancer

4. Tamoxifen for early breast cancer: an overview of the randomised trials

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Care Disparities: Overcoming Barriers to Cancer Control in Low- and Middle-Income Countries;JCO Global Oncology;2024-08

2. Breast cancer with biomarker reversal during the course of treatment: a case report;Journal of Surgical Case Reports;2024-06

3. Importance of Biomarker Conversions as “Road Signs” to Manage Women with Metastatic Breast Cancer: How To Use Them for Personalized Care of These Patients?;The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach;2023-12-18

4. Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer;Gene;2023-01

5. Can we define breast cancer HER2 status by liquid biopsy?;International Review of Cell and Molecular Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3